Sonoma Pharmaceuticals (SNOA) News Today $3.53 +0.45 (+14.61%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$3.54 +0.02 (+0.42%) As of 03/14/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sonoma Pharmaceuticals expands into UK marketMarch 12, 2025 | uk.investing.comWhy Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value InvestorsMarch 11, 2025 | msn.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in OrlandoFebruary 27, 2025 | finanznachrichten.deIs Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Worth US$2.7 Based On Its Intrinsic Value?February 7, 2025 | uk.finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial ResultsFebruary 6, 2025 | finanznachrichten.deSonoma Pharmaceuticals secures new supply agreementJanuary 31, 2025 | msn.comSonoma Pharmaceuticals, Inc. (O8Z.F)November 22, 2024 | uk.finance.yahoo.comSonoma Pharmaceuticals announces relaunch of dermatology, eye care linesNovember 22, 2024 | markets.businessinsider.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United StatesNovember 21, 2024 | finanznachrichten.deSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care HydrogelNovember 12, 2024 | finanznachrichten.deFDA grants Sonoma 510(k) approval for Microdacyn HydrogelNovember 12, 2024 | markets.businessinsider.comSonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor ConferencesOctober 22, 2024 | stockhouse.comSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?Sonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above 200 Day Moving Average - Should You Sell?October 11, 2024 | marketbeat.comSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comSonoma Pharmaceuticals (NASDAQ:SNOA) Shares Cross Above Two Hundred Day Moving Average of $0.33Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200-Day Moving Average of $0.33September 20, 2024 | marketbeat.comShort Interest in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Drops By 65.4%Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA - Get Free Report) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 130,300 shares, a decline of 65.4% from the August 15th total of 376,200 shares. Currently, 13.0% of the shares of the company are short sold. Based on an average trading volume of 192,400 shares, the days-to-cover ratio is currently 0.7 days.September 12, 2024 | marketbeat.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product LineSeptember 11, 2024 | finanznachrichten.deSonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above 200 Day Moving Average of $0.23Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Passes Above 200 Day Moving Average of $0.23August 31, 2024 | marketbeat.comSonoma Pharmaceuticals Inc (O8Z3.MU)August 30, 2024 | uk.finance.yahoo.comWhy Sonoma Pharmaceuticals (SNOA) Stock Is MovingAugust 28, 2024 | benzinga.comSonoma Pharmaceuticals First Quarter 2025 Earnings: Misses ExpectationsAugust 12, 2024 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial ResultsAugust 9, 2024 | finanznachrichten.deSNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025August 9, 2024 | investorplace.comSonoma Pharmaceuticals, Inc. (SNOA)July 20, 2024 | finance.yahoo.comSNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024June 17, 2024 | investorplace.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement StoresMay 9, 2024 | finanznachrichten.deSonoma Pharmaceuticals Inc.April 30, 2024 | money.usnews.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesApril 9, 2024 | finanznachrichten.deSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor ConferencesMarch 28, 2024 | finanznachrichten.deSonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 10, 2024 | finance.yahoo.comSonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial ResultsFebruary 8, 2024 | finance.yahoo.comSonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily UseJanuary 23, 2024 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsNovember 13, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsNovember 13, 2023 | finance.yahoo.comSonoma Pharmaceuticals Inc SNOANovember 11, 2023 | morningstar.comSonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall ConferenceNovember 3, 2023 | finance.yahoo.comUS Stocks Mixed; Bristol Myers Posts Upbeat EarningsOctober 26, 2023 | benzinga.comCrude Oil Down 2.5%; Mastercard Posts Upbeat EarningsOctober 26, 2023 | markets.businessinsider.comDow Dips Over 100 Points; US GDP Growth Tops ExpectationsOctober 26, 2023 | benzinga.comSonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common StockOctober 26, 2023 | finance.yahoo.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62%October 24, 2023 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 0.62%October 24, 2023 | msn.commacOS SonomaSeptember 28, 2023 | macrumors.comNational Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn AdvancedAugust 15, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial ResultsAugust 10, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial ResultsAugust 10, 2023 | finance.yahoo.comSonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory BoardAugust 3, 2023 | finance.yahoo.comSonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsJune 22, 2023 | finanznachrichten.deSonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial ResultsJune 22, 2023 | finance.yahoo.comSonoma Pharmaceuticals Shares Soar 44% After Introducing New ProductJune 9, 2023 | finance.yahoo.com Remove Ads Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address SNOA Media Mentions By Week SNOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNOA News Sentiment▼0.900.78▲Average Medical News Sentiment SNOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNOA Articles This Week▼30▲SNOA Articles Average Week Remove Ads Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IN8bio News Today Lipocine News Today Cognition Therapeutics News Today GlycoMimetics News Today Senti Biosciences News Today Carisma Therapeutics News Today BioAtla News Today OnKure Therapeutics News Today Cocrystal Pharma News Today Marker Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNOA) was last updated on 3/17/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNOA Stock Alerts